We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
-5.85%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$35.2B
AUM Growth
-$3.94B
(-10%)
Cap. Flow
-$1.12B
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
1,273
New
111
Increased
414
Reduced
514
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$63.8M |
| 2 |
Align Technology
ALGN
|
+$61.4M |
| 3 |
Stellantis
STLA
|
+$54.4M |
| 4 |
UBS Group
UBS
|
+$49.7M |
| 5 |
Republic Services
RSG
|
+$44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$73.1M |
| 2 |
IPG Photonics
IPGP
|
+$62.1M |
| 3 |
Adobe
ADBE
|
+$61.1M |
| 4 |
UnitedHealth
UNH
|
+$56.3M |
| 5 |
Apple
AAPL
|
+$54.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.86% |
| 2 | Healthcare | 17.08% |
| 3 | Financials | 11.33% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Industrials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Travere Therapeutics
TVTX
$6B
| $4.68M | 0.01% |
181,633
+160,233
| +749% | +$4.25M |
|
627
Oneok
OKE
$59.3B
| $4.64M | 0.01% |
65,687
+13,992
| +27% | +$895K |
|
628
FedEx
FDX
$71.8B
| $4.62M | 0.01% |
19,970
-46
| -0.2% | -$10.8K |
|
629
Nu Skin
NUS
$230M
| $4.61M | 0.01% |
96,300
-17,400
| -15% | -$862K |
|
|
TPH
630
DELISTED
Tri Pointe Homes
TPH
| $4.6M | 0.01% |
229,000
+42,800
| +23% | +$994K |
|
631
Landstar System
LSTR
$5.78B
| $4.57M | 0.01% |
30,300
+4,200
| +16% | +$668K |
|
632
Savara
SVRA
$1.08B
| $4.56M | 0.01% |
3,477,832
+37
| +0% | +$45 |
|
633
EPR Properties
EPR
$4.46B
| $4.54M | 0.01% |
+83,061
| New | +$4.02M |
|
634
Sabra Healthcare REIT
SBRA
$5.18B
| $4.54M | 0.01% |
304,746
-91,500
| -23% | -$1.25M |
|
635
Knowles
KN
$3.02B
| $4.52M | 0.01% |
209,800
-4,600
| -2% | -$101K |
|
636
Williams Companies
WMB
$87.7B
| $4.47M | 0.01% |
133,728
+73,711
| +123% | +$2.25M |
|
637
Cogent Biosciences
COGT
$5.71B
| $4.47M | 0.01% |
596,394
+7
| +0% | +$49 |
|
|
CERE
638
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $4.47M | 0.01% |
+127,590
| New | +$3.73M |
|
639
Cerence
CRNC
$361M
| $4.45M | 0.01% |
123,400
+42,101
| +52% | +$2.07M |
|
640
Algonquin Power & Utilities
AQN
$4.1B
| $4.43M | 0.01% |
285,301
-15,764
| -5% | -$227K |
|
641
Resideo Technologies
REZI
$2.87B
| $4.42M | 0.01% |
+185,400
| New | +$4.65M |
|
642
Group 1 Automotive
GPI
$3.22B
| $4.41M | 0.01% |
26,300
+1,600
| +6% | +$291K |
|
|
CSGS
643
DELISTED
CSG Systems International
CSGS
| $4.41M | 0.01% |
69,300
-3,300
| -5% | -$199K |
|
644
PVH
PVH
$3.39B
| $4.4M | 0.01% |
57,400
+31,500
| +122% | +$2.92M |
|
645
Sunrun
RUN
$2.03B
| $4.39M | 0.01% |
144,400
-16,000
| -10% | -$446K |
|
646
Freeport-McMoran
FCX
$100B
| $4.38M | 0.01% |
+88,014
| New | +$3.9M |
|
647
Fox Factory Holding Corp
FOXF
$818M
| $4.34M | 0.01% |
44,334
| – | – |
|
648
Qiagen
QGEN
$8.88B
| $4.34M | 0.01% |
83,459
+17,745
| +27% | +$916K |
|
649
The Ensign Group
ENSG
$10.3B
| $4.32M | 0.01% |
48,000
-4,100
| -8% | -$332K |
|
650
Mine Safety
MSA
$6.93B
| $4.31M | 0.01% |
32,512
-11,956
| -27% | -$1.65M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2022 Portfolio in Review
As of Q1 2022, Axa held 1,273 positions worth $35.2B, down 10% from $39.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Axa withdrew a net $1.12B in Q1 2022, closing 94 positions and reducing 514 holdings. Its most notable exit was Zai Lab, an estimated $21.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Freshpet worth $30.3M.
- Axa's largest Q1 2022 buy was Freshpet: 294,939 shares worth $30.3M.
- Axa added most to Pfizer in Q1 2022, an estimated $63.8M increase.
- Axa's biggest Q1 2022 reduction was Ferrari, cutting an estimated $73.1M.
- Axa fully exited Zai Lab in Q1 2022, selling an estimated $21.3M.
- Axa's ten largest holdings make up 20% of its $35.2B portfolio in Q1 2022.
- Axa opened 111 new positions and closed 94 in Q1 2022.
- Axa's portfolio value fell 10% quarter-over-quarter to $35.2B.
Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.